Key Highlights

● Arbe Robotics amended two tranches of warrants covering 16,263,732 ordinary shares issued originally on November 4, 2024.

● Tranche A exercise prices were cut to $1.10 per share, with termination extended to November 4, 2030.

● Tranche B exercise prices were cut to $1.00 per share, with termination extended to November 4, 2029.

● The filing does not disclose the original exercise prices, termination dates, or the company's rationale for the amendment.

Arbe Robotics Ltd. (NASDAQ:ARBE), an Israel-based radar chipmaker for the automotive industry, has agreed to cut the exercise prices and extend the terms of warrants covering more than 16 million of its ordinary shares. The company disclosed the amendment in a 6-K filed September 25, 2026.

The Warrants Being Amended

The warrants at issue were originally issued on November 4, 2024, and are split into two tranches of 8,131,866 warrants each, together covering 16,263,732 ordinary shares. Under the amendment agreement, Arbe agreed to "amend the Existing A Warrants to (i) reduce the exercise price to $1.10 per Ordinary Share and (ii) extend the termination date to November 4, 2030." The Tranche B warrants were separately amended to cut their exercise price to $1.00 per share and extend their termination date to November 4, 2029, one year earlier than the Tranche A extension.

In practice, this means holders of these warrants can now buy Arbe shares more cheaply than under the original terms, and they have more time to do so before the warrants expire. A Warrant is a security giving its holder the right, but not the obligation, to purchase shares at a set price before a set expiration date; companies often issue them alongside other securities as a sweetener in a financing transaction. The original November 2024 issuance of these Tranche A and Tranche B warrants would itself have accompanied some earlier Capital raise or strategic transaction, though this particular 6-K addresses only the amendment terms rather than recapping that original deal.

Why Companies Amend Warrant Terms

Reducing a warrant's exercise price and extending its life makes the warrant more valuable to its holder, since the option to buy shares becomes cheaper and remains available longer. Companies sometimes negotiate such amendments to encourage warrant holders to exercise their warrants sooner, which would bring in cash to the company, or to accommodate the wishes of large or strategic warrant holders. The 6-K filed by Arbe does not state the company's reason for agreeing to these changes, nor does it disclose whether the amendment was tied to any exercise commitment by the warrant holders or any other concession made in exchange.

Arbe's Business

Arbe Robotics develops radar-on-chip technology intended to give vehicles high-resolution perception for advanced driver assistance systems and autonomous driving applications. The company's warrant amendment agreement, filed as Exhibit 10.1 to the 6-K, sets out the mechanics of the changes described above, and the 6-K itself was furnished under cover appropriate for a foreign private issuer's periodic disclosure obligations.

What the Filing Does Not Say

The filing does not disclose the original, pre-amendment exercise prices or original termination dates for either tranche of warrants, making it impossible from this document alone to quantify exactly how much cheaper or how much longer-lived the warrants have become in percentage terms. It also does not name the warrant holders, state how many warrants have already been exercised, if any, or disclose what Arbe would receive in proceeds if all 16,263,732 warrants were exercised at their new, lower prices. No rationale for the amendment appears anywhere in the filing.

Monitoring Future Warrant Exercise Activity

With Tranche A warrants now running to November 4, 2030 and Tranche B to November 4, 2029, investors should watch Arbe's subsequent filings for any disclosure of warrant exercises, which would show up as new shares issued and cash proceeds received by the company.